153 related articles for article (PubMed ID: 2505970)
1. Effect of an oral contraceptive in primary dysmenorrhea--changes in uterine activity and reactivity to agonists.
Ekström P; Juchnicka E; Laudanski T; Akerlund M
Contraception; 1989 Jul; 40(1):39-47. PubMed ID: 2505970
[TBL] [Abstract][Full Text] [Related]
2. The influence of a combined oral contraceptive on uterine activity and reactivity to agonists in primary dysmenorrhea.
Hauksson A; Ekström P; Juchnicka E; Laudański T; Akerlund M
Acta Obstet Gynecol Scand; 1989; 68(1):31-4. PubMed ID: 2801028
[TBL] [Abstract][Full Text] [Related]
3. Plasma concentrations of vasopressin and a prostaglandin F2 alpha metabolite in women with primary dysmenorrhoea before and during treatment with a combined oral contraceptive.
Hauksson A; Akerlund M; Forsling ML; Kindahl H
J Endocrinol; 1987 Nov; 115(2):355-61. PubMed ID: 3125302
[TBL] [Abstract][Full Text] [Related]
4. Effect of an oral contraceptive on uterine tonicity in women with primary dysmenorrhea.
Lalos O; Joelsson I
Acta Obstet Gynecol Scand; 1981; 60(3):229-32. PubMed ID: 7270089
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of vasopressin release in women with primary dysmenorrhoea and after oral contraceptive treatment--effect on uterine contractility.
Ekström P; Akerlund M; Forsling M; Kindahl H; Laudanski T; Mrugacz G
Br J Obstet Gynaecol; 1992 Aug; 99(8):680-4. PubMed ID: 1390475
[TBL] [Abstract][Full Text] [Related]
6. Traditional Chinese medicine Guizhi Fuling capsule used for therapy of dysmenorrhea via attenuating uterus contraction.
Sun L; Liu L; Zong S; Wang Z; Zhou J; Xu Z; Ding G; Xiao W; Kou J
J Ethnopharmacol; 2016 Sep; 191():273-279. PubMed ID: 27340106
[TBL] [Abstract][Full Text] [Related]
7. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
Smith SK; Kirkman RJ; Arce BB; McNeilly AS; Loudon NB; Baird DT
Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of vasopressin effects on the uterus by a synthetic analogue.
Akerlund M; Strömberg P; Forsling ML; Melin P; Vilhardt H
Obstet Gynecol; 1983 Sep; 62(3):309-12. PubMed ID: 6877687
[TBL] [Abstract][Full Text] [Related]
9. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
10. Effects of a vasopressin antagonist in women with dysmenorrhea.
Valentin L; Sladkevicius P; Kindahl H; Broeders A; Marsal K; Melin P
Gynecol Obstet Invest; 2000; 50(3):170-7. PubMed ID: 11014949
[TBL] [Abstract][Full Text] [Related]
11. [Influence of naloxone on uterine contractions in patients with primary dysmenorrhea].
Mrugacz G; Grygoruk C; Sieczyński P; Grusza M; Pietrewicz P; Pietrzycki B
Pol Merkur Lekarski; 2013 Sep; 35(207):151-3. PubMed ID: 24224452
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the effect of high-intensity transcutaneous nerve stimulation and oral naproxen on intrauterine pressure and menstrual pain in patients with primary dysmenorrhea.
Milsom I; Hedner N; Mannheimer C
Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):123-9. PubMed ID: 8296814
[TBL] [Abstract][Full Text] [Related]
13. A comparison of two different oral contraceptives in patients with severe primary dysmenorrhoea.
Uysal G; Akkaya H; Cagli F; Tutus S; Tayyar AT
J Obstet Gynaecol; 2018 Aug; 38(6):828-832. PubMed ID: 29537325
[TBL] [Abstract][Full Text] [Related]
14. A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
Wilson ES; Cruickshank J; McMaster M; Weir RJ
Br J Obstet Gynaecol; 1984 Dec; 91(12):1254-60. PubMed ID: 6440589
[TBL] [Abstract][Full Text] [Related]
15. The influence of different combined oral contraceptives on the prevalence and severity of dysmenorrhea.
Milsom I; Sundell G; Andersch B
Contraception; 1990 Nov; 42(5):497-506. PubMed ID: 2125545
[TBL] [Abstract][Full Text] [Related]
16. The effect of oral contraceptives on uterine contractility and menstrual pain: an assessment with cine MR imaging.
Kido A; Togashi K; Kataoka M; Maetani Y; Nakai A; Kataoka ML; Koyama T; Fujii S
Hum Reprod; 2007 Jul; 22(7):2066-71. PubMed ID: 17567596
[TBL] [Abstract][Full Text] [Related]
17. Estradiol valerate plus dienogest versus ethinylestradiol plus levonorgestrel for the treatment of primary dysmenorrhea.
Petraglia F; Parke S; Serrani M; Mellinger U; Römer T
Int J Gynaecol Obstet; 2014 Jun; 125(3):270-4. PubMed ID: 24713413
[TBL] [Abstract][Full Text] [Related]
18. Dysmenorrhea.
Dawood MY
J Reprod Med; 1985 Mar; 30(3):154-67. PubMed ID: 3158737
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy of Fructus agni casti in women with severe primary dysmenorrhea: a prospective comparative Doppler study.
Aksoy AN; Gözükara I; Kabil Kucur S
J Obstet Gynaecol Res; 2014 Mar; 40(3):779-84. PubMed ID: 24245554
[TBL] [Abstract][Full Text] [Related]
20. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
Vercellini P; Trespidi L; Colombo A; Vendola N; Marchini M; Crosignani PG
Fertil Steril; 1993 Jul; 60(1):75-9. PubMed ID: 8513962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
